Literature DB >> 11940055

Severe hypomagnesaemia-induced hypocalcaemia in a patient with Gitelman's syndrome.

Paola Pantanetti1, Giorgio Arnaldi, Giancarlo Balercia, Franco Mantero, Gilberta Giacchetti.   

Abstract

Gitelman's syndrome (GS) is characterized by hyperreninaemic hyperaldosteronism, hypokalaemia, metabolic alkalosis, hypomagnesaemia and hypocalciuria and is due to a defect of the Na-Cl cotransporter at the distal tubule, which may appear in a sporadic or in a familial form. It is an autosomal recessive disorder associated with normal or reduced blood pressure. We report a case of severe hypomagnesaemia-induced hypocalcaemia in a 39-year-old Caucasian woman with GS. The patient had impaired parathormone (PTH) responsiveness to peripheral stimuli, as proved by the marked PTH increase and normalization of plasma calcium levels after acute and chronic administration of magnesium salts. Secondary normotensive hyperreninaemic hyperaldosteronism with hypokalaemia and metabolic alkalosis was also present. Normal plasma renin activity (PRA) and aldosterone levels were restored by administration of an inhibitor of prostaglandin synthesis. The electrolyte imbalance was successfully corrected with chronic treatment with magnesium and potassium salts. Genetic analysis identified a compound heterozygous mutation in the Na-Cl cotransporter gene (NCCT), confirming the diagnosis of GS. The striking feature of this case of GS was impaired PTH responsiveness to peripheral stimuli determined by hypomagnesaemia and the resulting severe hypocalcaemia, which had not previously been described in this syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11940055     DOI: 10.1046/j.1365-2265.2002.01223.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  3 in total

1.  A rare case of Gitelman's syndrome presenting with hypocalcemia and osteopenia.

Authors:  A Nakamura; C Shimizu; S Nagai; S Taniguchi; M Umetsu; T Atsumi; N Yoshioka; Y Ono; T Tajima; M Kubo; T Koike
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

2.  Gitelman's syndrome with hyperphosphatemia, effectively responding to single oral magnesium oxide administration: A case report.

Authors:  Aika Miya; Akinobu Nakamura; Hiraku Kameda; Kandai Nozu; Hideaki Miyoshi; Tatsuya Atsumi
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

3.  Gitelman syndrome: A case report.

Authors:  Shi-Yuan Chen; Ning Jie
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.